Evolution of psoriatic arthritis study patient population characteristics in the era of biological treatments by Kurt de Vlam, Ann-Sophie Vandendorpe, Rik Lories

Get full text

Triple jump for the optimal management of psoriatic arthritis: diet, sleep and exercise – a review by Ennio Lubrano, Kurt de Vlam, Rik Lories, Silvia Scriffignano, Fabio Massimo Perrotta, Mario Ronga

Get full text

Can a Commercially Available Smartwatch Device Accurately Measure Nighttime Sleep Outcomes in Individuals with Knee Osteoarthritis and Comorbid Insomnia? A Comparison with Home-Bas... by Céline Labie, Nils Runge, Zosia Goossens, Olivier Mairesse, Jo Nijs, Anneleen Malfliet, Dieter Van Assche, Kurt de Vlam, Luca Menghini, Sabine Verschueren, Liesbet De Baets

Get full text

Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden—a phase III study of active psoriatic arthritis in patients with an inadequate response to con... by Philip J Mease, Dafna D Gladman, Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, Daniela Graham, Cunshan Wang, Joseph C Cappelleri, Thijs Hendrikx, Ming-Ann Hsu

Get full text

Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, ran... by Philip J Mease, Dafna D Gladman, Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, Joseph C Cappelleri, Thijs Hendrikx, Ming-Ann Hsu, Linda Chen, Elizabeth Kudlacz, Joseph Wu

Get full text